BioCardia, Inc.
BCDA
$1.83
-$0.04-2.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | -- | 3.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | -- | 3.00K |
| Cost of Revenue | 1.37M | 1.53M | -1.56M | 931.00K | 800.00K |
| Gross Profit | -1.37M | -1.53M | 1.56M | -931.00K | -797.00K |
| SG&A Expenses | 683.00K | 1.20M | 906.00K | 825.00K | 852.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.05M | 2.73M | 2.32M | 1.76M | 1.65M |
| Operating Income | -2.05M | -2.73M | -2.32M | -1.76M | -1.65M |
| Income Before Tax | -2.05M | -2.71M | -2.30M | -1.74M | -1.65M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.05M | -2.71M | -2.30M | -1.74M | -1.65M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.05M | -2.71M | -2.30M | -1.74M | -1.65M |
| EBIT | -2.05M | -2.73M | -2.32M | -1.76M | -1.65M |
| EBITDA | -2.05M | -2.71M | -2.31M | -1.74M | -1.63M |
| EPS Basic | -0.41 | -0.59 | -0.50 | -0.61 | -0.88 |
| Normalized Basic EPS | -0.25 | -0.37 | -0.31 | -0.38 | -0.55 |
| EPS Diluted | -0.41 | -0.59 | -1.00 | -0.61 | -0.88 |
| Normalized Diluted EPS | -0.25 | -0.37 | -0.31 | -0.38 | -0.55 |
| Average Basic Shares Outstanding | 5.06M | 4.64M | 4.59M | 2.83M | 1.88M |
| Average Diluted Shares Outstanding | 5.06M | 4.64M | 4.59M | 2.83M | 1.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |